新冠疫苗的成功研发,对全球疫情防控和经济复苏以及筑牢国家生物安全屏障具有重要意义。本文在对疫苗产业特征和产业链分析的基础上,从全球新冠疫苗研发的参与国家及研发速度、不同技术路线、产业链及产业体系、龙头企业产能及市场占有率等多个视角进行梳理,分析全球新冠疫苗研发的竞争格局;并对中国新冠疫苗的全饱和式研发技术路线、产学研合作及疫苗研发国际合作方面的成效进行梳理,展望了中国在加强针疫苗研发和深度参与疫苗国际公共产品提供方面的未来方向。从政策层面出发,需要加强基础研究和技术能力储备,以新冠疫苗研发为契机培育优秀头部企业,增强疫苗产业链的稳定性和竞争力,加快评审审批和提高企业创新积极性,加强疫苗研发生物安全领域国际合作,从而增强中国疫苗产业链创新链竞争力。
The successful research and development of COVID-19 vaccine is of great significance to global epidemic prevention and control,economic recovery and building a national biosafety barrier. Based on the analysis of vaccine industry characteristics and industrial chain,the global competition pattern of COVID-19 vaccine was analyzed from the perspectives of participating countries and development speed,different vaccine platforms,industrial chain and industrial system,production capacity and market share of leading enterprises in this chapter. It also analyzed the full saturation development platform of China’s COVID-19 vaccine,the achievements of industry university research cooperation and international cooperation in vaccine development,and looked forward to China’s future direction in strengthening the upgrading of immunization and vaccine renewal needs and in-depth participation in the provision of vaccine as international public goods. From the policy level,it is necessary to strengthen the basic research and reserve of technical capacity,take the COVID-19 vaccine development as an opportunity to cultivate excellent leading enterprises,enhance the stability and competitiveness of the vaccine industrial chain,speed up the review and approval,improve the innovation enthusiasm of enterprises,and strengthen international cooperation in the biosafety field of vaccine research and development,so as to enhance the competitiveness of China’s vaccine industrial chain and innovation chain.